Acacia Research Corp.

As of March 13, 2025, Acacia Research Corp. is considered risky and overvalued, with a high P/E ratio of 63 compared to its peers and poor return metrics, including a year-to-date return of -21.66% versus the S&P 500's 12.22%.

As of March 13, 2025, Acacia Research Corp. is considered risky and overvalued due to a high P/E ratio of 63, low return metrics, and underperformance compared to the S&P 500.

As of May 8, 2025, the trend is mildly bearish due to daily moving averages and monthly indicators showing bearish signals, despite some short-term strength from weekly indicators, while the stock has significantly underperformed the S&P 500.

As of March 2022, the management team of Acacia Research Corp. includes Ms. Maureen O'Connell (Independent Chairman), Mr. Alfred Tobia (President and Chief Investment Officer), Mr. Clifford Press (CEO), and independent directors Mr. Isaac Kohlberg, Mr. Jonathan Sagal, and Ms. Katharine Wolanyk. They are responsible for the company's strategic direction and operations.

Acacia Research Corporation invests in, licenses, and enforces patented technologies, operating as a micro-cap company with a market cap of $370.86 million. As of March 2025, it reported net sales of $124 million and a net profit of $24 million.

As of Jun 18, Acacia Research Corp. has a market capitalization of 370.86 million, with net sales of 222.41 million and a net profit of -10.98 million over the latest four quarters. Shareholder's funds total 514.83 million, and total assets are reported at 756.39 million.